Abubakar M., 12

Twelve-year-old Abubakar lived with his grandmother in a small, mud-brick house on the outskirts of Gashua. Their home, with its worn, patched roof, offered little in the way of comfort, especially during the harsh dry season when dust devils danced through the fields, or the rainy season when the roof would sometimes weep in tiny, persistent drips. They were, by any measure, less privileged, a fact that weighed heavily on Femi’s young shoulders, even if he didn’t always have the words for it. Abubakar a 12-year-old boy experience a rapidly deteriorating condition of severe malaria the breakdown categorized by symptoms when brought to Ayaji are High Fever, Headache, Body Aches and Joint Pain, Nausea and Vomiting Frequent and forceful vomiting, which can lead to dehydration As hat this is a description of the untreated progression. On presentation at the hospital, he was evaluated and diagnosed with Severe Malaria.

Abubakar a 12-year-old boy was brought to Ayaji hospital with a history of high fever, headaches, vomiting, and extreme fatigue. His parents also noted a decreased appetite and irritability, which progressed to lethargy and a brief seizure. A physical examination revealed an enlarged spleen and a blood smear confirmed the diagnosis of severe malaria. Thank you Helpster charity for the support, the patient was admitted and received free medical intervention and prescribed with some * IV Artesunate * IV Paracetamol * IV Metronidazole * Syrup Fammot (Artmether) * Syrup Metronidazole The patient has since made a full recovery, with his fever and other symptoms subsiding, and he is now back to his normal activities, feeling healthy and energetic his mother give an prayer to Helpstercharity to prosper.

Severe malaria is a medical emergency requiring immediate and aggressive treatment. Every minute counts as symptoms can deteriorate rapidly. * Parenteral Antimalarials: * Intravenous (IV) artesunate: This is the primary treatment recommended by the WHO for severe malaria in all patients, including infants, pregnant women, and lactating women. Treatment with IV artesunate should be initiated as soon as possible and continued for at least 24 hours until the patient can tolerate oral medication. * If IV artesunate is not immediately available, other parenteral antimalarials like quinine may be used as an alternative, or oral antimalarials can be given until artesunate becomes available. * Supportive Care: Patients with severe malaria require admission to a hospital and close monitoring. Supportive care is crucial and may include: * Fluid management. * Correction of electrolyte imbalances. * Management of convulsions. * Blood transfusions for severe anemia. * Management of respiratory distress. * Monitoring and treatment of hypoglycemia. * Addressing any other organ dysfunction. * Transition to Oral Therapy: Once the patient has received at least 24 hours of parenteral therapy and can tolerate oral medications, treatment should be completed with a full three-day course of an artemisinin-based combination therapy (ACT). Complications: Severe malaria can lead to various serious complications, including: * Cerebral malaria (with potential for permanent neurological damage) * Severe anemia * Acute kidney injury/failure * Acute respiratory distress syndrome (ARDS) * Hypoglycemia * Metabolic acidosis * Liver failure and jaundice * Circulatory collapse/shock * Abnormal bleeding * Splenic rupture (less common) In pregnant women, severe malaria also increases the risk of premature birth, low birth weight, stillbirth, miscarriage, and maternal mortality.